Skip to main content
SpringerLink
Log in

Prediction of Pharmacokinetic Parameters and the Assessment of Their Variability in Bioequivalence Studies by Artificial Neural Networks

  • Published:
Pharmaceutical Research Aims and scope Submit manuscript

Abstract

Purpose. The methodology of predicting the pharmacokinetic parameters (AUC, cmax, tmax) and the assessment of their variability in bioequivalence studies has been developed with the use of artificial neural networks.

Methods. The data sets included results of 3 distinct bioequivalence studies of oral verapamil products, involving a total of 98 subjects and 312 drug applications. The modeling process involved building feedforward/backpropagation neural networks. Models for pharmacokinetic parameter prediction were also used for the assessment of their variability and for detecting the most influential variables for selected pharmacokinetic parameters. Variables of input neurons based on logistic parameters of the bioequivalence study, clinical-biochemical parameters, and the physical examination of individuals.

Results. The average absolute prediction errors of the neural networks for AUC, cmax, and tmax prediction were: 30.54%, 39.56% and 30.74%, respectively. A sensitivity analysis demonstrated that for verapamil the three most influential variables assigned to input neurons were: total protein concentration, aspartate aminotransferase (AST) levels, and heart-rate for AUC, AST levels, total proteins and alanine aminotransferase (ALT) levels, for cmax, and the presence of food, blood pressure, and body-frame for tmax.

Conclusions. The developed methodology could supply inclusion or exclusion criteria for subjects to be included in bioequivalence studies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

REFERENCES

  1. S-C. Chow and J-P. Liu. Design and Analysis of Bioavailability and Bioequivalence Studies, Marcel Dekker, New York, 1992.

    Google Scholar 

  2. R. J. Erb. Introduction to backpropagation neural network computation. Pharm. Res. 10:165–170 (1993).

    Google Scholar 

  3. M. E. Brier, J. M. Zurada, and G. R. Aronoff. Neural network predicted peak and trough gentamicin concentrations. Pharm. Res. 12:406–412 (1995).

    Google Scholar 

  4. A. S. Hussain, R. D. Johnson, N. N. Vachharajani, and W. A. Ritschel. Feasibility of developing a neural network for prediction of human pharmacokinetic parameters from animal data. Pharm. Res. 10:466–469 (1993).

    Google Scholar 

  5. R. C. Rowe. Intelligent software systems for pharmaceutical product formulation. Pharm. Technol. Eur. 9:36–43 (1997).

    Google Scholar 

  6. E. A. Colbourn and R. C. Rowe. Modelling and optimization of a tablet formulation using neural networks and genetic algorithms. Pharm. Technol. Eur. 8:46–55 (1996).

    Google Scholar 

  7. R. Hecht-Nielsen. Neurocomputing, Addison-Wesley, Reading, MA, 1990.

    Google Scholar 

  8. W. A. Ritschel, R Akileswaran, and A. S. Hussain. Application of neural networks for the prediction of human pharmacokinetic parameters. Meth. Find. Exp. Clin. Pharmacol. 17:629–643 (1995).

    Google Scholar 

  9. B. J. A Krose and P. P. van der Smagt. An Introduction to Neural Networks, The University of Amsterdam, 1993.

  10. A. S. Hussain, P. Shivanand, and R. D. Johnson. Application of neural computing in pharmaceutical product development: Computer aided formulation design. Drug Dev. Ind. Pharm. 20:1739–1752 (1994).

    Google Scholar 

  11. A. S. Achanta, J. G. Kowalski, and C. T. Rhodes. Artificial neural networks: Implications for pharmaceutical sciences, Drug Dev. Ind. Pharm. 21:119–155 (1995).

    Google Scholar 

  12. P. Veng-Pedersen and N. B. Modi. Neural networks in pharmaco-dynamic modeling. Is current modeling practice of complex kinetic systems at a dead end? J. Pharmacokinet. Biopharm. 20:397–412 (1992).

    Google Scholar 

  13. J. V. S. Gobburu and E. P. Chen. Artificial neural networks as a novel approach to integrated pharmacokinetic-pharmacodynamic analysis. J. Pharm. Sci. 85:505–510 (1996).

    Google Scholar 

  14. L. B. Sheiner and S. L Beal. Some suggestions for measuring predictive performance. J. Pharmacokinet. Biopharm. 9:503–512 (1981).

    Google Scholar 

  15. NNMODEL Version 1.40, User's guide, Neural Fusion, New York, 1996.

  16. J. Zupan. Usage of computer methods in chemistry, DZS, Ljubljana, 1992.

    Google Scholar 

  17. V. W. Steinijans, R. Sauter, D. Hauschke, E. Diletti, R. Schall, H. G. Luus, M. Elze, H. Blume, C. Hoffmann, G. Franke, and W. Siegmund. Reference tables for the intrasubject coefficient of variation in bioequivalence studies. Int. J. Clin. Pharm. Ther. 33:427–430 (1995).

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Faculty of Pharmacy, University of Ljubljana, Slovenia

    Jerneja Opara & Stanislav Primožič

  2. Lek d.d. Ljubljana, Verovškova 57, Ljubljana, Slovenia

    Polona Cvelbar

Authors
  1. Jerneja Opara
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Stanislav Primožič
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Polona Cvelbar
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jerneja Opara.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Opara, J., Primožič, S. & Cvelbar, P. Prediction of Pharmacokinetic Parameters and the Assessment of Their Variability in Bioequivalence Studies by Artificial Neural Networks. Pharm Res 16, 944–948 (1999). https://doi.org/10.1023/A:1018857108713

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1018857108713

Search

Navigation